IBDEI1WA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33324,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,33324,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,33325,0)
 ;;=D86.2^^182^2002^46
 ;;^UTILITY(U,$J,358.3,33325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33325,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,33325,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,33325,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,33326,0)
 ;;=D86.89^^182^2002^48
 ;;^UTILITY(U,$J,358.3,33326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33326,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,33326,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,33326,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,33327,0)
 ;;=D86.9^^182^2002^51
 ;;^UTILITY(U,$J,358.3,33327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33327,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,33327,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,33327,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,33328,0)
 ;;=D86.86^^182^2002^39
 ;;^UTILITY(U,$J,358.3,33328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33328,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,33328,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,33328,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,33329,0)
 ;;=D86.87^^182^2002^43
 ;;^UTILITY(U,$J,358.3,33329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33329,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,33329,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,33329,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,33330,0)
 ;;=D86.3^^182^2002^49
 ;;^UTILITY(U,$J,358.3,33330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33330,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,33330,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,33330,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,33331,0)
 ;;=D86.81^^182^2002^41
 ;;^UTILITY(U,$J,358.3,33331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33331,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,33331,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,33331,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,33332,0)
 ;;=D86.82^^182^2002^50
 ;;^UTILITY(U,$J,358.3,33332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33332,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,33332,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,33332,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,33333,0)
 ;;=D86.84^^182^2002^44
 ;;^UTILITY(U,$J,358.3,33333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33333,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,33333,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,33333,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,33334,0)
 ;;=D86.85^^182^2002^42
 ;;^UTILITY(U,$J,358.3,33334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33334,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,33334,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,33334,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,33335,0)
 ;;=D86.83^^182^2002^40
 ;;^UTILITY(U,$J,358.3,33335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33335,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,33335,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,33335,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,33336,0)
 ;;=D84.1^^182^2002^17
 ;;^UTILITY(U,$J,358.3,33336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33336,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,33336,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,33336,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,33337,0)
 ;;=D81.810^^182^2002^7
 ;;^UTILITY(U,$J,358.3,33337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33337,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,33337,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,33337,2)
 ;;=^5002422
 ;;
 ;;$END ROU IBDEI1WA
